Encompass Health Corp. 8-K Summary
Business Context and Reporting Period
Encompass Health Corporation (EHC) filed this Form 8-K on August 5, 2026, to report financial results for the three and six months ended June 30, 2026. The filing incorporates a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) detailing the Company's operational performance. The Company utilizes "same-store" comparisons for performance metrics, which include results from market consolidation and capacity expansions in existing markets.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the attached exhibits for these figures. The Company highlights the following non-GAAP measures as critical to its financial assessment:
- Adjusted Earnings Per Share: Excludes government settlements, professional fees, mark-to-market adjustments, hedging gains/losses, debt extinguishment losses, tax provision adjustments, and restructuring items.
- Leverage Ratio: Defined as consolidated total debt to Adjusted EBITDA for the trailing four quarters. The credit agreement permits deducting cash on hand from total debt.
- Adjusted EBITDA: Used as a primary liquidity measure and a key component of credit agreement covenants. It adjusts net income by adding back interest, taxes, depreciation, amortization, and specific non-recurring items (capped at $10 million for cash expenditures).
- Adjusted Free Cash Flow: Defined as net cash from operating activities minus maintenance capital expenditures, distributions to noncontrolling interests, and non-indicative items. Common stock dividends are excluded.
Material Changes and Comparisons
The filing does not contain specific data regarding material changes in financial metrics versus the prior comparable period. It notes that same-store comparisons are used to explain changes in performance metrics but does not quantify these changes in the text provided. Investors are directed to the press release and supplemental information for detailed period-over-period analysis.
Guidance, Outlook, and Risks
The filing includes a comprehensive "Forward-Looking Statements" section. Management's outlook and guidance are subject to various risks and uncertainties, including:
- Future legislation or regulation impacting the healthcare sector.
- Labor cost trends and growth targets.
- Financial plans, dividend strategies, and debt/equity repurchase plans.
- Projected capital expenditures and development plans.
Covenant Risks: The Company's credit agreement contains material covenants regarding the interest coverage ratio and leverage ratio. Noncompliance could trigger immediate repayment of all borrowed amounts, prohibit additional indebtedness, restrict dividend payments, and limit asset acquisitions or dispositions. The Company states that Adjusted EBITDA is critical to assessing liquidity and covenant compliance.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial results for the quarter and six months ended June 30, 2026.
- Verify the reconciliation of Adjusted EBITDA to net income and Adjusted Free Cash Flow to operating cash flow in Exhibit 99.2.
- Confirm the Company's current leverage ratio and interest coverage ratio against credit agreement covenants.
- Assess the magnitude of excluded items in Adjusted Earnings Per Share to understand the variance from GAAP earnings.
- Monitor the upcoming earnings call scheduled for August 6, 2026, for management commentary on forward-looking guidance.